Clinical trial / 2009
Daily sesamin supplementation decreased blood pressure in adults with mild hypertension.
Twenty-five middle-aged individuals with mild hypertension completed a cross-over trial comparing 60 mg daily of encapsulated sesamin against placebo across two 4-week periods separated by a washout. Sesamin intake significantly decreased systolic blood pressure from 137.6 to 134.1 mmHg (p=0.044) and diastolic blood pressure from 87.7 to 85.8 mmHg (p=0.045). In contrast, placebo treatment produced no meaningful changes in blood pressure readings.
- Study type
- Double-blind, cross-over, placebo-controlled trial
- Who was studied
- 25 middle-aged adults with mild hypertension
- What was measured
- Systolic and diastolic blood pressure
THE PAPER
Antihypertensive effects of sesamin in humans.
Miyawaki T, Aono H, Toyoda-Ono Y, Maeda H, Kiso Y, Moriyama K. J Nutr Sci Vitaminol (Tokyo), 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.